3-Acetoxy-8(17),13E-labdadien-15-oic acid | CAS:63399-37-1

3-Acetoxy-8(17),13E-labdadien-15-oic acid

ChemFaces products have been cited in many studies from excellent and top scientific journals

Product Name	3-Acetoxy-8(17),13E-labdadien-15-oic acid
Price:
CAS No.:	63399-37-1
Catalog No.:	CFN97090
Molecular Formula:	C₂₂H₃₄O₄
Molecular Weight:	362.5 g/mol
Purity:	>=98%
Type of Compound:	Diterpenoids
Physical Desc.:	Powder
Source:	The rhizomes of Cibotium barometz (L.) J.Sm.
Solvent:	Chloroform, Dichloromethane, Ethyl Acetate, DMSO, Acetone, etc.
Download:	COA MSDS SDF
Similar structural:	Comparison (Web) (SDF)
Guestbook:

Order & Inquiry & Tech Support

Tel: (0086)-27-84237683
Tech: service@chemfaces.com
Order: manager@chemfaces.com
Address: 176, CheCheng Eest Rd., WETDZ, Wuhan, Hubei 430056, PRC

How to Order

Orders via your E-mail:

1. Product number / Name / CAS No.
2. Delivery address
3. Ordering/billing address
4. Contact information
Order: manager@chemfaces.com

Delivery time

Delivery & Payment method

1. Usually delivery time: Next day delivery by 9:00 a.m. Order now

2. We accept: Wire transfer & Credit card & Paypal

Citing Use of our Products

More Impact Factor than five Cite...

* Packaging according to customer requirements(5mg, 10mg, 20mg and more). We shipped via FedEx, DHL, UPS, EMS and others courier.

According to end customer requirements, ChemFaces provide solvent format. This solvent format of product intended use: Signaling Inhibitors, Biological activities or Pharmacological activities.

Size /Price /Stock	10 mM * 1 mL in DMSO / Inquiry
Other Packaging	*Packaging according to customer requirements(100uL/well, 200uL/well and more), and Container use Storage Tube With Screw Cap

Featured Products

More...

D-(-)-Salicin

Catalog No: CFN99541
CAS No: 138-52-3
Price: $30/20mg

Soyasaponin Ab

Catalog No: CFN90773
CAS No: 118194-13-1
Price: $ / mg

Calenduloside E

Catalog No: CFN91169
CAS No: 26020-14-4
Price: $268/10mg

Calceolarioside A

Catalog No: CFN98522
CAS No: 84744-28-5
Price: $ /

Tanshinone IIA

Catalog No: CFN98952
CAS No: 568-72-9
Price: $30/20mg

Danshensu

Catalog No: CFN99539
CAS No: 22681-72-7
Price: $70/20mg

Poncirin

Catalog No: CFN90448
CAS No: 14941-08-3
Price: $168/20mg

Alisol B 23-acetate

Catalog No: CFN99753
CAS No: 26575-95-1
Price: $50/20mg

Kukoamine A

Catalog No: CFN93215
CAS No: 75288-96-9
Price: $ / mg

DL-Syringaresinol

Catalog No: CFN99276
CAS No: 1177-14-6
Price: $ /

Description:

ent-3-Acetoxy-labda-8(17),13-dien-15-oic acid have vasorelaxant and hypotensive actions, the mechanisms underlying the cardiovascular actions of the labdane involve the activation of the endothelial NO-cGMP pathway, the opening of K+ channels and the alteration on Ca2+ mobilization.

Targets:

Calcium Channel | cAMP | Potassium Channel | NO

In vivo:

Eur J Pharmacol. 2014 Mar 5;726:66-76.

Mechanisms underlying the vascular and hypotensive actions of the labdane ent-3-acetoxy-labda-8(17),13-dien-15-oic acid.[Pubmed: 24463178 ]

We investigated the mechanisms underlying the vasorelaxant and hypotensive actions of the labdane-type diterpene ent-3-acetoxy-labda-8(17),13-dien-15-oic acid (3-Acetoxy-8(17),13E-labdadien-15-oic acid,labda-15-oic acid).
METHODS AND RESULTS:
Vascular reactivity experiments were performed in aortic rings isolated from male Wistar rats. cAMP and cGMP were measured by enzyme immunoassay (EIA) whereas nitrate measurement was performed by chemiluminescence. Nitric oxide (NO) concentration ([NO]c) was measured in endothelial cells by flow cytometry. The cytosolic calcium concentration ([Ca2+]c) in vascular smooth muscle cells (VSMC) was measured by confocal microscopy. Blood pressure measurements were performed in conscious rats. Labda-15-oic acid inhibited the contraction induced by phenylephrine and serotonin in either endothelium-intact or endothelium-denuded rat aortic rings. The labdane significantly reduced CaCl2-induced contraction in a Ca2+-free solution containing KCl or phenylephrine. Labda-15-oic acid (0.1–300 μmol/l) concentration-dependently relaxed endothelium-intact and endothelium-denuded aortas pre-contracted with either phenylephrine or KCl. In endothelium-intact rings, the relaxation induced by labda-15-oic acid was affected by L-NAME, 7-nitroindazole, ODQ, hemoglobin, Rp-8-Br-Pet-cGMPS and thapsigargin. Blockade of K+ channels with 4-aminopyridine, apamin, charybdotoxin and glibenclamide affected the relaxation induced by labda-15-oic acid. The labdane increased cGMP and nitrate levels but did not affect cAMP levels in endothelium-intact aortas. Labda-15-oic acid increased [NO]c in endothelial cells and decreased [Ca2+]c in VSMC. The hypotension induced by intravenous administration of labda-15-oic acid (0.3–3 mg/kg) was partially reduced by L-NAME.
CONCLUSIONS:
In conclusion, the mechanisms underlying the cardiovascular actions of the labdane involve the activation of the endothelial NO-cGMP pathway, the opening of K+ channels and the alteration on Ca2+ mobilization.

3-Acetoxy-8(17),13E-labdadien-15-oic acid Description

Source:	The rhizomes of Cibotium barometz (L.) J.Sm.
Solvent:	Chloroform, Dichloromethane, Ethyl Acetate, DMSO, Acetone, etc.
Storage:	Providing storage is as stated on the product vial and the vial is kept tightly sealed, the product can be stored for up to 24 months(2-8C). Wherever possible, you should prepare and use solutions on the same day. However, if you need to make up stock solutions in advance, we recommend that you store the solution as aliquots in tightly sealed vials at -20C. Generally, these will be useable for up to two weeks. Before use, and prior to opening the vial we recommend that you allow your product to equilibrate to room temperature for at least 1 hour. Need more advice on solubility, usage and handling? Please email to: service@chemfaces.com
After receiving:	The packaging of the product may have turned upside down during transportation, resulting in the natural compounds adhering to the neck or cap of the vial. take the vial out of its packaging and gently shake to let the compounds fall to the bottom of the vial. for liquid products, centrifuge at 200-500 RPM to gather the liquid at the bottom of the vial. try to avoid loss or contamination during handling.

Size /Price /Stock	10 mM * 100 uL in DMSO / Inquiry / In-stock 10 mM * 1 mL in DMSO / Inquiry / In-stock
Related Libraries	Antihypertensive Compound Library Vasorelaxation Compound Library Diterpenoids Compound Library Potassium Channel Inhibitor Library NO Inhibitor Library cAMP Inhibitor Library Calcium Channel Inhibitor Library

	1 mg	5 mg	10 mg	20 mg	25 mg
1 mM	2.7586 mL	13.7931 mL	27.5862 mL	55.1724 mL	68.9655 mL
5 mM	0.5517 mL	2.7586 mL	5.5172 mL	11.0345 mL	13.7931 mL
10 mM	0.2759 mL	1.3793 mL	2.7586 mL	5.5172 mL	6.8966 mL
50 mM	0.0552 mL	0.2759 mL	0.5517 mL	1.1034 mL	1.3793 mL
100 mM	0.0276 mL	0.1379 mL	0.2759 mL	0.5517 mL	0.6897 mL

CFN97440	ent-14,15-Dinor-13-oxolabda-8(17),11-dien-18-oic acid	875585-30-1	290.4	C₁₈H₂₆O₃
CFN92778	Coronadiene	1145689-64-0	262.4	C₁₇H₂₆O₂
CFN99058	15-Nor-14-oxolabda-8(17),12-dien-18-oic acid	1039673-32-9	304.4	C₁₉H₂₈O₃
CFN89382	Junicedric acid	41787-69-3	336.46	C₂₀H₃₂O₄
CFN92779	Zerumin A	176050-48-9	318.5	C₂₀H₃₀O₃
CFN97091	Alepterolic acid	63399-38-2	320.5	C₂₀H₃₂O₃
CFN97090	3-Acetoxy-8(17),13E-labdadien-15-oic acid	63399-37-1	362.5	C₂₂H₃₄O₄
CFN89391	ent-3beta,18-Dihydroxylabda-8(17),13E-dien-15-oic acid	99624-39-2	336.46	C₂₀H₃₂O₄
CFN99412	9-Hydroxy-13E-labden-15-oic acid	132915-47-0	322.5	C₂₀H₃₄O₃
CFN95862	Callicapoic acid M1	2756970-65-5	336.5	C₂₀H₃₂O₄